Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Hypersusceptibility to invasive pneumococcal infection in experimental sickle cell disease involves platelet-activating factor receptor.

Miller ML, Gao G, Pestina T, Persons D, Tuomanen E.

J Infect Dis. 2007 Feb 15;195(4):581-4. Epub 2007 Jan 8.

PMID:
17230418
2.

Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice.

Rijneveld AW, Weijer S, Florquin S, Speelman P, Shimizu T, Ishii S, van der Poll T.

J Infect Dis. 2004 Feb 15;189(4):711-6. Epub 2004 Jan 30.

PMID:
14767826
3.

Exposure to welding fumes and lower airway infection with Streptococcus pneumoniae.

Suri R, Periselneris J, Lanone S, Zeidler-Erdely PC, Melton G, Palmer KT, Andujar P, Antonini JM, Cohignac V, Erdely A, Jose RJ, Mudway I, Brown J, Grigg J.

J Allergy Clin Immunol. 2016 Feb;137(2):527-534.e7. doi: 10.1016/j.jaci.2015.06.033. Epub 2015 Aug 12.

4.

Signalling or binding: the role of the platelet-activating factor receptor in invasive pneumococcal disease.

Iovino F, Brouwer MC, van de Beek D, Molema G, Bijlsma JJ.

Cell Microbiol. 2013 Jun;15(6):870-81. doi: 10.1111/cmi.12129. Epub 2013 Mar 20. Review.

PMID:
23444839
5.

Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease.

Rosch JW, Boyd AR, Hinojosa E, Pestina T, Hu Y, Persons DA, Orihuela CJ, Tuomanen EI.

J Clin Invest. 2010 Feb;120(2):627-35. doi: 10.1172/JCI39843. Epub 2010 Jan 19.

6.

Prevotella intermedia induces severe bacteremic pneumococcal pneumonia in mice with upregulated platelet-activating factor receptor expression.

Nagaoka K, Yanagihara K, Morinaga Y, Nakamura S, Harada T, Hasegawa H, Izumikawa K, Ishimatsu Y, Kakeya H, Nishimura M, Kohno S.

Infect Immun. 2014 Feb;82(2):587-93. doi: 10.1128/IAI.00943-13. Epub 2013 Nov 18.

7.

Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice.

Garcia CC, Russo RC, Guabiraba R, Fagundes CT, Polidoro RB, Tavares LP, Salgado AP, Cassali GD, Sousa LP, Machado AV, Teixeira MM.

PLoS Pathog. 2010 Nov 4;6(11):e1001171. doi: 10.1371/journal.ppat.1001171.

8.

beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae.

Radin JN, Orihuela CJ, Murti G, Guglielmo C, Murray PJ, Tuomanen EI.

Infect Immun. 2005 Dec;73(12):7827-35. Erratum in: Infect Immun. 2006 May;74(5):3078.

9.

The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza.

McCullers JA, Iverson AR, McKeon R, Murray PJ.

Scand J Infect Dis. 2008;40(1):11-7. Epub 2007 Jun 21.

10.

Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection.

Souza DG, Fagundes CT, Sousa LP, Amaral FA, Souza RS, Souza AL, Kroon EG, Sachs D, Cunha FQ, Bukin E, Atrasheuskaya A, Ignatyev G, Teixeira MM.

Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14138-43. doi: 10.1073/pnas.0906467106. Epub 2009 Jul 30.

11.

Pneumococcal infection of respiratory cells exposed to welding fumes; Role of oxidative stress and HIF-1 alpha.

Grigg J, Miyashita L, Suri R.

PLoS One. 2017 Mar 9;12(3):e0173569. doi: 10.1371/journal.pone.0173569. eCollection 2017.

12.

The platelet activating factor receptor: a new anti-infective target in respiratory disease?

Grigg J.

Thorax. 2012 Sep;67(9):840-1. doi: 10.1136/thoraxjnl-2012-202206. Epub 2012 Jul 16. Review.

PMID:
22802333
13.
14.
15.

Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia.

van der Sluijs KF, van Elden LJ, Nijhuis M, Schuurman R, Florquin S, Shimizu T, Ishii S, Jansen HM, Lutter R, van der Poll T.

Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L194-9. Epub 2005 Aug 12.

16.

Cigarette smoke and platelet-activating factor receptor dependent adhesion of Streptococcus pneumoniae to lower airway cells.

Grigg J, Walters H, Sohal SS, Wood-Baker R, Reid DW, Xu CB, Edvinsson L, Morissette MC, Stämpfli MR, Kirwan M, Koh L, Suri R, Mushtaq N.

Thorax. 2012 Oct;67(10):908-13. doi: 10.1136/thoraxjnl-2011-200835. Epub 2012 May 1.

PMID:
22550083
17.
18.

Platelet Activating Factor (PAF) Receptor Deletion or Antagonism Attenuates Severe HSV-1 Meningoencephalitis.

Vilela MC, Lima GK, Rodrigues DH, Lacerda-Queiroz N, Pedroso VS, de Miranda AS, Rachid MA, Kroon EG, Campos MA, Teixeira MM, Teixeira AL.

J Neuroimmune Pharmacol. 2016 Dec;11(4):613-621. Epub 2016 May 19.

PMID:
27193134
19.

Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology.

Fillon S, Soulis K, Rajasekaran S, Benedict-Hamilton H, Radin JN, Orihuela CJ, El Kasmi KC, Murti G, Kaushal D, Gaber MW, Weber JR, Murray PJ, Tuomanen EI.

J Immunol. 2006 Nov 1;177(9):6182-91.

20.

Central role of PAFR signalling in ExoU-induced NF-κB activation.

Mallet de Lima CD, da Conceição Costa J, de Oliveira Lima Santos SA, Carvalho S, de Carvalho L, Albano RM, Teixeira MM, Plotkowski MC, Saliba AM.

Cell Microbiol. 2014 Aug;16(8):1244-54. doi: 10.1111/cmi.12280. Epub 2014 Mar 21.

PMID:
24612488

Supplemental Content

Support Center